- Research works
- 2 ▼ 50% vs 2013–17
- Citations
- 14 8.1 per fractional work
- Top-10% rate
- 11.6% record average 16.5%
- Open access
- 41% world 28%
Not ranked overall: Perseus PCI (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Perseus PCI (United States) publish most on?
By volume: Immunotherapy and Immune Responses, Cancer Research and Treatments, Cancer Immunotherapy and Biomarkers and T-cell and B-cell Immunology.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Immunotherapy and Immune Responses Immunology 1 works
- 2 Cancer Research and Treatments Biotechnology 0 works
- 3 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 4 T-cell and B-cell Immunology Immunology 0 works
- 5 Virus-based gene therapy research Genetics 0 works
- 6 vaccines and immunoinformatics approaches Molecular Biology 0 works
- 7 Cutaneous Melanoma Detection and Management Oncology 0 works
- 8 Ubiquitin and proteasome pathways Molecular Biology 0 works
- 9 Hepatitis B Virus Studies Epidemiology 0 works
- 10 RNA Interference and Gene Delivery Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Perseus PCI (United States)'s research output changed?
Output in 2018–2022 was 50% lower than in 2013–2017.
Other research institutions in Simpsonville
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.